Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics

Major bleeding risks associated with non-vitamin K oral anticoagulants (NOACs) used with and without concurrent antipsychotics in patients with non-valvular atrial fibrillation (AF) were assessed. A total of 98,863 patients with non-valvular AF receiving at least one NOAC prescription from Taiwan’s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chiung-Mei, Chang, Kuo-Hsuan, Wang, Chun-Li, Tu, Hui-Tzu, Huang, Yu-Tung, Wu, Hsiu-Chuan, Chang, Chien-Hung, Chang, Shang-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046567/
https://www.ncbi.nlm.nih.gov/pubmed/35496319
http://dx.doi.org/10.3389/fphar.2022.819878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046567/
https://www.ncbi.nlm.nih.gov/pubmed/35496319
http://dx.doi.org/10.3389/fphar.2022.819878

Ejemplares similares